45 reports

  • Untitled
  • 12.2 SERVICE PROVIDERS

The plant breeding and CRISPR plants market is projected to grow at a CAGR of 13.95% from 2018 to 2023. The plant breeding and CRISPR plants market is projected to reach USD 14.6 billion by 2023, from USD 7.6 billion in 2018, at a CAGR of 13.95%. The plant breeding and CRISPR plants market is driven by various factors such...

  • Agricultural Products
  • DuPont
  • Evogene Ltd.
  • Monsanto Company
  • Syngenta AG
  • Gene Expression and Genetic Mapping 107
  • GLOBAL MARKET FOR GENE EXPRESSION AND GENETIC MAPPING BY

This BCC Research report explores the current and future PCR product market, which includes instruments, reagents and consumables, and software and services. It also looks at innovations, market drivers and forces holding back the market. Market forecast provided from 2016 through 2021. Use this report to: Analyze...

  • In Vitro Diagnostics
  • Molecular Diagnostic
  • World
  • GLOBAL PCR BASED GENE EXPRESSION & GENETIC MAPPING APPLICATIONS MARKET, BY REGION, (2014-2022) ($MN)
  • NORTH AMERICANPCR BIOMEDICAL RESEARCH APPLICATION MARKET, BY TYPE, (2014-2022) ($MN)

Polymerase Chain Reaction (PCR) is a novel technique which doubles the amount of target DNA in every cycle. The PCR has three steps such as denaturation, annealing and extension, which are repeated in every cycle to achieve the product. PCR market has been divided as products, applications, techniques, end users and geography. PCR products...

  • Molecular Diagnostic
  • World
  • Market Size
  • bioMerieux S.A.
  • GE Healthcare Limited
  • EXECUTIVE SUMMARY
  • PRODUCTS & SERVICES

Moreover, knowing one' s genetic code will enable a person to make adequate lifestyle and environmental changes (based on the growing field of epigenetic research) at an early age to avoid or lessen the severityof a genetic disease.

  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • Monsanto Company
  • Pfizer Inc.
  • Roche Group
  • Cost per analysis
  • FEATURE DIFFERENCE BETWEEN SNP, SSR, AND OTHER MOLECULAR MARKERS

Genetic markers and multiple genetically different strains of the organism are the two major pre-requisites for QTL mapping.

  • Grains
  • Livestock
  • North America
  • United States
  • Illumina, Inc.
  • Appendix

Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects.

  • Dementia
  • Monoclonal Antibody
  • Psychotic Disorder
  • Therapy
  • World
  • 6.2.1 Biomeb: A company providing genetic and metabolic counseling and novel

As genetic mapping, databases and technologies become more widely available and less expensive, the ability for companies to provide high-quality services at low cost to consumers and healthcare providers is increasing, which opens the opportunity for considerable growth within the

  • Functional Food
  • Nutraceutical
  • World
  • Danone SA
  • Nestlé S.A.
  • APAC: CANCER BIOMARKERS MARKET FOR PROTEOMICS, BY COUNTRY, 2015-2022 (USD MILLION)
  • CANCER BIOMARKERS MARKET FOR GENOMICS, BY TYPE, 2015-2022 (USD MILLION)

Researchers in genomics strive to determine complete DNA sequences and perform genetic mapping to help understand diseases.

  • Biomarker
  • Cancer Biomarker
  • Genomics
  • North America
  • United States
  • TYPE1 DIABETES (JUVENILE DIABETES) - PIPELINE BY APODEMUS AB,
  • TYPE1 DIABETES (JUVENILE DIABETES) - PIPELINE BY APHIOS CORP,

The company develops tools for patient diagnosis and techniques for genetic mapping of disease causing viral strains.

  • Chronic Disease
  • Diabetes
  • Pathology
  • Pharmaceutical
  • Therapy
  • 5.4.25 APPLIED RESEARCH USING OMIC SCIENCES SL
  • ALZHEIMER'S DISEASE - PIPELINE BY APPLIED RESEARCH USING OMIC SCIENCES SL

The company develops tools for patient diagnosis and techniques for genetic mapping of disease causing viral strains.

  • Dementia
  • Mental Health
  • Pathology
  • Pharmaceutical
  • Therapy
  • PRODUCTS & SERVICES CONTINUED
  • Products and services segmentation (2018-19)

These include using genetic mapping methods to identify disease-resistant animals and to determine which genes are related to health problems.

  • Biotechnology
  • United Kingdom
  • Products and services segmentation (2018)
  • PRODUCTS & SERVICES

Over the past decade, the selective breeding process has quickly shifted toward cloning, particularly now that farmers can identify disease-resistant and desirable breeds through DNA and genetic mapping tests, which has helped to create new industry products.

  • Veterinary Healthcare
  • United States
  • Demand
  • Merck & Co., Inc.
  • Zoetis Inc.
  • PRODUCTS & SERVICES CONTINUED
  • Products and services segmentation (2018-19)

Biotechnology also provides powerful tools to improve farm animal breeding programs, including genetic mapping methods to identify disease-resistant animals and specific These applications aim to produce larger genes related to health defects.

  • Biotechnology
  • Australia
  • THREATS

Biochips are primarily used in genome mapping and sequencing.

  • Graphene
  • Microchip
  • Smart Glass
  • United States
  • Samsung Electronics Co., Ltd.
  • Products & Markets
  • Products & Markets

Moreover, knowing one' s genetic code will enable a person to make adequate lifestyle and environmental changes at an early age so as to avoid or lessen the severity of a genetic disease.

  • United States
  • AbbVie Inc.
  • Genentech, Inc.
  • Gilead Sciences, Inc.
  • Monsanto Company
  • 4 IN-VITRO DIAGNOSTICS GLOBAL MARKET, BY TECHNOLOGY

GENETIC SEQUENCING CAN BE USED TO IDENTIFY INFECTIOUS DISEASE PATHOGENS BY MAPPING THEIR UNIQUE GENETIC MAKEUP.

  • In Vitro Diagnostics
  • Medical Device
  • World
  • Market Size
  • bioMerieux S.A.
  • ROW: NGS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • 10.5 REST OF THE WORLD (ROW)

EGL conducts about ##, ## tests every year for genetic diseases, prenatal testing, and carrier screening. ## ##. ##. ##. ## ## ##. ##. ##. ## In January 2015, QIAGEN N.

  • Genome Sequencing
  • Molecular Diagnostic
  • North America
  • United States
  • Illumina, Inc.
  • PARTNERSHIP

Under the collaboration, drought-tolerant African maize will be developed by CIMMYT will be crossed with Syngenta varieties bred for Asia, applying Syngenta' s genetic mapping technology to speed and refine the selection of high-yielding, drought-tolerant maize varieties.

  • Grains
  • Maize
  • United States
  • M&A
  • Syngenta AG
  • PARTNERSHIP

Under the collaboration, drought-tolerant African maize will be developed by CIMMYT will be crossed with Syngenta varieties bred for Asia, applying Syngenta' s genetic mapping technology to speed and refine the selection of high-yielding, drought-tolerant maize varieties.

  • Grains
  • Maize
  • United States
  • M&A
  • Syngenta AG
  • 4.2.2 SEQUENCING

GENERATES ACCURATE REFERENCE SEQUENCE FROM A SMALL GENOME TO COMPLEX GENOME AND PROVIDES ACCURATE INFORMATION FOR GENETIC MAPPING OF DIFFERENT LEVEL OF ORGANISMS.

  • Biological Therapy
  • Biotechnology
  • Cell Analysis
  • Molecular Diagnostic
  • World
  • PARTNERSHIP - DEAL REPORTS

The company' s research is focused on projects which include: chemical mutagenesis, mutation detection, and genetic mapping; In vitro culture and phenotype analysis; applied molecular biology and genetic transformation; molecular diagnostics; and bioinformatics.

  • Healthcare
  • Pharmaceutical
  • United States
  • Corporate Finance
  • Dyax Corp.
  • 1.1 OVERVIEW
  • Overview of Microarrays

This field includes trying to determine the entire DNA sequence of organisms and fine-scale genetic mapping.

  • Bioinformatic
  • Molecular Diagnostic
  • Protein Microarray
  • Proteomics
  • Illumina, Inc.
  • JUL 19, 2018: CRISPR-BASED TOOL MAPS GENE FUNCTION IN HUMAN CELLS

PCMI will first tackle autism spectrum disorder (ASD), one of the best genetically-characterized disorders, with ## genes identified.

  • Health Services
  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • AGRIGENOMICS MARKET SNAPSHOT, 2016 VS. 2021 (USD BILLION)
  • EXECUTIVE SUMMARY

The compilation of genomic database through DNA sequencing and analysis has led to innovation ideas on genetic mapping.

  • Genome Sequencing
  • United States
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • AGRIGENOMICS MARKET SNAPSHOT, 2016 VS. 2021 (USD BILLION)
  • EXECUTIVE SUMMARY

The compilation of genomic database through DNA sequencing and analysis has led to innovation ideas on genetic mapping.

  • Genome Sequencing
  • United States
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Description

Molecular Diagnostics 2016 Market Study ##.

  • Diagnostics
  • Genomics
  • In Vitro Diagnostics
  • Molecular Diagnostic
  • Pathology
  • Description

Key Features ##.

  • In Vitro Diagnostics
  • Molecular Diagnostic
  • World
  • APCETH BIOPHARMA GMBH
  • TYPE1 DIABETES (JUVENILE DIABETES) - PIPELINE BY ARECOR LTD, H1 2018

The company develops tools for patient diagnosis and techniques for genetic mapping of disease causing viral strains.

  • Chronic Disease
  • Diabetes
  • Insulin
  • Pathology
  • Therapy
  • OTHER CELLS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • 7.4 OTHER CELLS

Plant cells are also used to prevent diseases from affecting a person in the future, depending on genetic mapping and profiling, protein profiling, and hereditary history, among other factors.

  • North America
  • United States
  • World
  • Market Size
  • Thermo Fisher Scientific, Inc.
  • Description

DNA Sequencing Markets: Global Analysis and Opportunity Evaluation 2016 - 2020 ##.

  • Genome Sequencing
  • Genomics